Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

PIPITONE, Rosaria Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.782
EU - Europa 3.202
AS - Asia 2.879
SA - Sud America 464
AF - Africa 87
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.446
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.686
SG - Singapore 1.069
RU - Federazione Russa 872
IT - Italia 828
CN - Cina 743
BR - Brasile 370
FI - Finlandia 353
HK - Hong Kong 280
VN - Vietnam 256
DE - Germania 233
PL - Polonia 168
UA - Ucraina 148
FR - Francia 134
GB - Regno Unito 126
IE - Irlanda 114
IN - India 96
JP - Giappone 84
KR - Corea 80
BD - Bangladesh 52
SE - Svezia 52
CA - Canada 41
AR - Argentina 40
TR - Turchia 37
IQ - Iraq 33
NL - Olanda 32
AT - Austria 28
MX - Messico 28
RO - Romania 23
AU - Australia 22
ID - Indonesia 22
CI - Costa d'Avorio 20
ZA - Sudafrica 18
CL - Cile 16
SA - Arabia Saudita 15
ES - Italia 14
GR - Grecia 14
BE - Belgio 13
IR - Iran 13
PK - Pakistan 13
EC - Ecuador 12
UZ - Uzbekistan 12
PH - Filippine 11
EG - Egitto 10
LT - Lituania 10
JO - Giordania 9
AZ - Azerbaigian 8
CO - Colombia 8
JM - Giamaica 8
BG - Bulgaria 6
MA - Marocco 6
MY - Malesia 6
NP - Nepal 6
PY - Paraguay 6
TN - Tunisia 6
AL - Albania 5
BY - Bielorussia 5
DZ - Algeria 5
LB - Libano 5
BO - Bolivia 4
CH - Svizzera 4
DK - Danimarca 4
HN - Honduras 4
NG - Nigeria 4
NI - Nicaragua 4
PA - Panama 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
CZ - Repubblica Ceca 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
KG - Kirghizistan 3
OM - Oman 3
PE - Perù 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CR - Costa Rica 2
CY - Cipro 2
ET - Etiopia 2
IL - Israele 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
VE - Venezuela 2
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
GD - Grenada 1
GI - Gibilterra 1
GT - Guatemala 1
GY - Guiana 1
Totale 13.432
Salva come PNG Salva come JPEG
Città #
Ashburn 879
Fairfield 879
Singapore 772
Woodbridge 406
Chandler 377
Houston 373
Seattle 330
Wilmington 324
Cambridge 286
San Jose 276
Hong Kong 261
Palermo 248
Ann Arbor 205
Moscow 155
Zgierz 141
Des Moines 121
Beijing 117
Dublin 111
New York 108
Ho Chi Minh City 105
Los Angeles 104
Medford 99
Helsinki 96
Santa Clara 90
Council Bluffs 88
Frankfurt am Main 75
Tokyo 75
Dallas 74
The Dalles 70
Altamura 68
Jacksonville 68
Lauterbourg 66
Princeton 65
Nanjing 64
Hanoi 63
Lawrence 60
Hefei 52
Rome 48
Chicago 40
San Diego 40
Boardman 36
Buffalo 34
Milan 34
São Paulo 31
London 30
Dearborn 29
Shenyang 29
Orem 28
Jinan 26
Seoul 25
Changsha 23
Nuremberg 23
Mumbai 22
Tulsa 22
Chennai 21
Jiaxing 21
Abidjan 20
San Paolo di Civitate 20
Hebei 19
Atlanta 18
Montreal 18
Nanchang 18
Phoenix 17
Warsaw 17
Washington 17
Baghdad 16
Brooklyn 16
Denver 16
Guangzhou 16
Ludwigshafen am Rhein 16
Izmir 15
Stockholm 15
Zhengzhou 15
Shanghai 14
Athens 13
Brussels 13
Brasília 12
Kumar 12
Amsterdam 11
Belo Horizonte 11
Johannesburg 11
Ningbo 11
Porto Alegre 11
Redondo Beach 11
Haiphong 10
Paris 10
Saint Petersburg 10
Tianjin 10
Amman 9
Boston 9
Central 9
Redwood City 9
Seongnam 9
Ankara 8
Baku 8
Bari 8
Da Nang 8
Taizhou 8
Tashkent 8
Curitiba 7
Totale 8.872
Salva come PNG Salva come JPEG
Nome #
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis 387
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease 298
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 295
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 286
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 284
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells 271
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 269
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors 252
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 251
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis 244
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 239
MAFLD: a multisystem disease 238
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease 237
Effects of Pimozide Derivatives on pSTAT5 in K562 Cells 231
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives 230
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. 226
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 226
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells 225
Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[2E]-3-phenylprop-2-enoylamino}benzamides 224
SYNTHESIS AND ANTIPROLIFERATIVE ACTIVITY OF 3-AMINO-N-PHENYL-1H-INDAZOLE-1-CARBOXAMIDES 222
Antiproliferative Agents That Interfere with the Cell Cycle at the G(1)-->S Transition: Further Development and Characterization of a Small Library of Stilbene-Derived Compounds 220
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity 218
Effetti antileucemici di due stilbeni identificati in uve provenienti da vigneti affetti da peronospora e Botrytis cinerea 217
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C 213
Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization. 210
The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells. 210
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 209
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides 207
Genetic predisposition to thrombophilia in inflammatory bowel disease 204
Identification of biphenyl-based hybrid molecules able to decrease the intracellular level of Bcl-2 protein in Bcl-2 overexpressing leukemia cells. 203
Substituted 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]thiophene derivatives as potent tubulin polymerization inhibitors 202
Correlation between the single nucleotide polymorphism (SNP) rs4374383 in MERTK gene with the risk of development and progression of liver disease 202
Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity 198
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 195
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 193
Statin use and non-alcoholic steatohepatitis in at risk individuals 192
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 190
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 181
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C 180
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease 177
Novel Terphenyls and 3,5-Diaryl Isoxazole Derivatives Endowed with Growth Supporting and Antiapoptotic Properties 173
EPIGENETIC PROFILING AND THERAPEUTICS IN LIVER DISEASE 161
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis 160
IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. 159
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 159
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction 156
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease 156
Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients. 152
Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line 151
The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis 150
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease 149
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 147
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV 146
SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study 146
The PD-1/PD-L1 Axis in the Biology of MASLD 142
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease 140
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 140
PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19 139
Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19, (S0168827823051474), (10.1016/j.jhep.2023.09.020)] 134
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-N,N-dimethylamino benzo[b]furan derivatives as inhibitors of tubulin polymerization 134
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivatives. 134
In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C 124
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease 124
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization 120
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene 119
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development 116
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease 115
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease 115
Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population 114
Red and golden tomato administration improves fat diet-induced hepatic steatosis in rats by modulating HNF4α, Lepr, and GK expression 108
Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin-22, interleukin-6 and interleukin-1Ra concentrations according to portal hypertension and disease severity 105
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease 105
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy 88
Liver follicular helper T-cells in chronic hepatitis C 74
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE 72
Correction to "Novel Antiproliferative Chimeric Compounds with Marked Histone Deacetylase Inhibitory Activity" 7
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 1
Totale 13.791
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.615
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021184 0 0 0 0 0 0 0 0 0 0 101 83
2021/2022891 57 187 25 29 23 32 50 59 94 114 76 145
2022/20231.187 107 240 23 113 107 196 104 80 125 7 55 30
2023/2024554 19 66 27 46 62 143 37 51 6 23 23 51
2024/20251.536 38 88 99 149 53 47 179 95 97 191 212 288
2025/20265.191 402 147 314 454 556 788 827 567 394 533 209 0
Totale 13.791